Patents by Inventor Sabine Bahn

Sabine Bahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATING SCHIZOPHRENIA BASED ON A PANEL OF BIOMARKERS
    Publication number: 20200319207
    Abstract: The invention relates to a method of differential diagnosis of schizophrenia or other psychotic disorder from a further psychiatric disorder.
    Type: Application
    Filed: November 8, 2019
    Publication date: October 8, 2020
    Inventors: Sabine Bahn, Emanuel Schwarz
  • Serum biomarker panels for bipolar disorder
    Patent number: 10739355
    Abstract: The invention relates to biomarkers and methods of diagnosing or monitoring bipolar disorder, or a predisposition thereto.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: August 11, 2020
    Assignee: Cambridge Enterprise Limited
    Inventors: Sabine Bahn, Jason Cooper, Frieder Haenisch
  • Treating schizophrenia based on a panel of biomarkers
    Patent number: 10527632
    Abstract: The invention relates to a method of differential diagnosis of schizophrenia or other psychotic disorder from a further psychiatric disorder.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: January 7, 2020
    Assignee: Cambridge Enterprise Limited
    Inventors: Sabine Bahn, Emanuel Schwarz
  • Quantifying biomarkers for diagnosing and treating schizophrenia, bipolar disorder or major depression
    Patent number: 10386362
    Abstract: The invention relates to a method of differentially diagnosing schizophrenia, bipolar disorder and major depressive disorder.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: August 20, 2019
    Assignee: Cambridge Enterprise Limited
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS
    Publication number: 20190094240
    Abstract: The invention relates to biomarkers and a method of diagnosing or monitoring depression, anxiety disorder or other psychotic disorder.
    Type: Application
    Filed: September 6, 2018
    Publication date: March 28, 2019
    Inventors: Sabine Bahn, Emanuel Schwarz, Brenda Penninx, Nicole Vogelzangs
  • Biomarkers associated with schizophrenia
    Patent number: 10197580
    Abstract: The invention relates to biomarkers and methods of diagnosing or monitoring schizophrenia, or a predisposition thereto.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: February 5, 2019
    Assignee: Cambridge Enterprises Limited
    Inventors: Sabine Bahn, Man Kuan Chan
  • Biomarkers
    Patent number: 10101338
    Abstract: The invention relates to biomarkers and a method of diagnosing or monitoring depression, anxiety disorder or other psychotic disorder.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: October 16, 2018
    Assignees: Cambridge Enterprise Limited, Stichting VU
    Inventors: Sabine Bahn, Emanuel Schwarz, Brenda Penninx, Nicole Vogelzangs
  • SERUM BIOMARKER PANELS FOR BIPOLAR DISORDER
    Publication number: 20180120331
    Abstract: The invention relates to biomarkers and methods of diagnosing or monitoring bipolar disorder, or a predisposition thereto.
    Type: Application
    Filed: January 15, 2016
    Publication date: May 3, 2018
    Inventors: Sabine Bahn, Jason Cooper, Frieder Haenisch
  • BIOMARKERS
    Publication number: 20170212102
    Abstract: The invention relates to a method of differentially diagnosing schizophrenia, bipolar disorder and major depressive disorder.
    Type: Application
    Filed: January 26, 2017
    Publication date: July 27, 2017
    Inventors: Sabine Bahn, Emanuel Schwarz
  • NOVEL BIOMARKERS
    Publication number: 20170016921
    Abstract: The invention relates to biomarkers and methods of diagnosing or monitoring schizophrenia, or a predisposition thereto.
    Type: Application
    Filed: March 9, 2015
    Publication date: January 19, 2017
    Inventors: Sabine BAHN, Man Kuan CHAN
  • Marker for response to antidepressant therapy
    Patent number: 9459266
    Abstract: The invention relates to the use of ApoA4 as biomarker for predicting whether a patient will respond to antidepressant treatment. The invention further relates to methods and kits for predicting whether a patient will respond to antidepressant treatment using said biomarker.
    Type: Grant
    Filed: May 13, 2014
    Date of Patent: October 4, 2016
    Assignee: Cambridge Enterprise Limited
    Inventors: Sabine Bahn, Man Kuan Chan, Viktoria Stelzhammer
  • MARKER FOR RESPONSE TO ANTIDEPRESSANT THERAPY
    Publication number: 20160116492
    Abstract: The invention relates to the use of ApoA4 as biomarker for predicting whether a patient will respond to antidepressant treatment. The invention further relates to methods and kits for predicting whether a patient will respond to antidepressant treatment using said biomarker.
    Type: Application
    Filed: May 13, 2014
    Publication date: April 28, 2016
    Inventors: Sabine BAHN, Man Kuan CHAN, Viktoria STELZHAMMER
  • BIOMARKERS
    Publication number: 20150099663
    Abstract: The invention relates to biomarkers and a method of diagnosing or monitoring depression, anxiety disorder or other psychotic disorder.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Sabine Bahn, Emanuel Schwarz, Brenda Pennix, Nicole Vogelzangs
  • BIOMARKERS
    Publication number: 20150005192
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 1, 2015
    Applicant: Cambridge Enterprise Limited
    Inventors: Sabine Bahn, Paul Guest, Laura Harris, Yishai Levin, Divya Krishnamurthy
  • BIOMARKERS
    Publication number: 20140200151
    Abstract: The invention relates to a method of differential diagnosis of schizophrenia or other psychotic disorder from a further psychiatric disorder.
    Type: Application
    Filed: December 20, 2011
    Publication date: July 17, 2014
    Applicant: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS
    Publication number: 20140200150
    Abstract: The invention relates to a method of differentially diagnosing schizophrenia, bipolar disorder and major depressive disorder.
    Type: Application
    Filed: December 20, 2011
    Publication date: July 17, 2014
    Applicant: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS FOR SCHIZOPHRENIA
    Publication number: 20130224221
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: March 31, 2011
    Publication date: August 29, 2013
    Applicant: PSYNOVA NEUROTECH LTD.
    Inventors: Sabine Bahn, Paul Guest, Laura Harris, Yishai Levin, Divya Krishnamurthy
  • BIOMARKERS
    Publication number: 20130178385
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.
    Type: Application
    Filed: May 18, 2011
    Publication date: July 11, 2013
    Applicant: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: Sabine Bahn, Emanuel Schwarz, Yishai Levin
  • BIOMARKERS
    Publication number: 20130171166
    Abstract: The invention relates to a method of diagnosing or monitoring major depressive disorder using MMP-3 as a biomarker.
    Type: Application
    Filed: March 31, 2011
    Publication date: July 4, 2013
    Applicant: PSYNOVA NEUROTECH LTD.
    Inventors: Sabine Bahn, Emanuel Schwarz
  • BIOMARKERS
    Publication number: 20130078645
    Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder. The biomarkers used are selected from cyclophilin A, cytosalic non-specific dipepditase, Caoctosin-like protein, Glucose-6-phosphate isomerase, uncharacterized protein KIAA0423, myosin 14, myosin 15, nicotinamide phosphoribosyltransferase, pyruvate kinase isozyme R/L, phosphoglyterate mutase 4.
    Type: Application
    Filed: January 28, 2011
    Publication date: March 28, 2013
    Applicant: PSYNOVA NEUROTECH LTD.
    Inventors: Sabine Bahn, Marlis Huebner